- Home
- CMPX vs FDBC Comparison
CMPX vs FDBC Comparison
Compare CMPX & FDBC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CMPX
- FDBC
- Stock Information
- Founded
- CMPX 2014
- FDBC 1902
- Country
- CMPX United States
- FDBC United States
- Employees
- CMPX N/A
- FDBC N/A
- Industry
- CMPX Biotechnology: Pharmaceutical Preparations
- FDBC Major Banks
- Sector
- CMPX Health Care
- FDBC Finance
- Exchange
- CMPX Nasdaq
- FDBC Nasdaq
- Market Cap
- CMPX 214.6M
- FDBC 253.4M
- IPO Year
- CMPX N/A
- FDBC N/A
- Fundamental
- Price
- CMPX $2.92
- FDBC $43.45
- Analyst Decision
- CMPX Strong Buy
- FDBC
- Analyst Count
- CMPX 6
- FDBC 0
- Target Price
- CMPX $12.50
- FDBC N/A
- AVG Volume (30 Days)
- CMPX 1.4M
- FDBC 6.1K
- Earning Date
- CMPX 03-20-2025
- FDBC 01-29-2025
- Dividend Yield
- CMPX N/A
- FDBC 3.68%
- EPS Growth
- CMPX N/A
- FDBC 12.85
- EPS
- CMPX N/A
- FDBC 3.60
- Revenue
- CMPX $850,000.00
- FDBC $79,413,000.00
- Revenue This Year
- CMPX N/A
- FDBC N/A
- Revenue Next Year
- CMPX $613.39
- FDBC N/A
- P/E Ratio
- CMPX N/A
- FDBC $12.07
- Revenue Growth
- CMPX N/A
- FDBC 9.77
- 52 Week Low
- CMPX $0.77
- FDBC $41.00
- 52 Week High
- CMPX $4.08
- FDBC $61.21
- Technical
- Relative Strength Index (RSI)
- CMPX 48.30
- FDBC 42.14
- Support Level
- CMPX $3.14
- FDBC $43.21
- Resistance Level
- CMPX $3.85
- FDBC $45.00
- Average True Range (ATR)
- CMPX 0.33
- FDBC 1.38
- MACD
- CMPX -0.11
- FDBC -0.05
- Stochastic Oscillator
- CMPX 5.68
- FDBC 12.97
About CMPX Compass Therapeutics Inc.
Compass Therapeutics Inc is a clinical-stage biopharmaceutical company that develops proprietary antibody therapeutics intended to engage the immune system to treat both solid tumors and hematological malignancies. It is engaged in drug discovery by leveraging its proprietary antibody discovery engine to broadly drug the immune system and identify optimal combinations empirically. Through StitchMabs and common light chain platforms, these combinatorial insights can be rapidly translated into tailored bispecifics with monoclonal-like manufacturability. Its pipeline is comprised of three product candidates, CTX-009, CTX-471, and CTX-8371.
About FDBC Fidelity D & D Bancorp Inc.
Fidelity D & D Bancorp Inc is a bank holding company. Through its wholly-owned state-chartered commercial bank subsidiary, The Fidelity Deposit and Discount Bank (the Bank), it offers a full range of traditional banking services. The Bank has a personal and corporate trust department and also provides alternative financial and insurance products with asset management services. Its primary market areas are Lackawanna, Luzerne and Northampton Counties, Pennsylvania. The company's primary deposit products are demand deposits and interest-bearing time, money market and savings accounts. It offers a full array of loan products to meet the needs of retail and commercial customers.